<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="17778" end="17784" sStart="17626" offset="152" sid="r11.strong.j.0268" wn="1" wnkey="strong%3:00:00::" annotator="vebatchelder" text="In the pRSVL74 derived plasmids, the luc gene encoding the very sensitive luciferase reporter is under the control of the strong Rous Sarcoma Virus promoter [ 24]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="15514" end="15522" sStart="null" offset="6" sid="r7.strike.v.0470" wn="2147483645" wnkey="null" annotator="jeneale" text="It is striking that the CAA UAG CAA UUA sequence directs a high readthrough in several very different eukaryotes." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2199-2-3.anc" start="17345" end="17350" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" annotator="carichter" text="The pRSVL74 cloning vector is &lt;b&gt;shown&lt;/b&gt; in Figure 1and the procedures used to construct the mutant derivatives have been described previously [ 25]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="5979" end="5984" sStart="null" offset="19" sid="r1.rule.v.0045" wn="2147483647" wnkey="null" annotator="sophiavv" text="These observations ruled out that the identity of the last amino acid was the main determinant of readthrough level." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="5979" end="5984" sStart="null" offset="19" sid="r1.rule.v.0045" wn="2147483647" wnkey="null" annotator="anfahmy" text="These observations ruled out that the identity of the last amino acid was the main determinant of readthrough level." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="5979" end="5984" sStart="null" offset="19" sid="r1.rule.v.0045" wn="2147483647" wnkey="null" annotator="adelpriore" text="These observations ruled out that the identity of the last amino acid was the main determinant of readthrough level." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="15305" end="15309" sStart="null" offset="129" sid="r7.poor.j.0959" wn="4" wnkey="poor%3:00:02::" annotator="brubin" text="If this is the case, one would predict to be able to obtain mutant forms of eRF1 showing a better recognition of poor codon context." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="1097" end="1107" sStart="null" offset="162" sid="r10.particular.j.0275" wn="2" wnkey="particular%5:00:02:specific:00" annotator="cgozo" text="This differs from the mechanism of selenocysteine incorporation, which requires a whole set of specific partners, including a specific tRNA and a particular elongation factor [ 4]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="1416" end="1426" sStart="null" offset="3" sid="r10.particular.j.0183" wn="2147483647" wnkey="null" annotator="cgozo" text="In particular, it has been demonstrated that the nucleotide following the stop codon (defined as +4) is non random, with purines over-represented for the three stop codons." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="6845" end="6855" sStart="null" offset="3" sid="r10.particular.j.0171" wn="2147483647" wnkey="null" annotator="cgozo" text="In particular, a strong bias is observed at the -1 position (see Figure 2C)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="2797" end="2803" sStart="null" offset="82" sid="r9.normal.j.0081" wn="1" wnkey="normal%3:00:01::" annotator="veweser" text="Elucidating the mechanisms at play during readthrough may help understand normal translation termination." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="822" end="828" sStart="null" offset="157" sid="r9.normal.j.0983" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="Up to now, no specific gene products have been implicated in the control of translational readthrough, strongly suggesting that only normal interactions between the mRNA and components of the translational machinery are involved." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="2797" end="2803" sStart="null" offset="82" sid="r9.normal.j.0081" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="Elucidating the mechanisms at play during readthrough may help understand normal translation termination." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="252" end="258" sStart="null" offset="119" sid="r9.normal.j.0264" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="Its accuracy reaches about 10 -4and ensures that only very few abnormal products are synthesised under normal conditions [ 1]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="2797" end="2803" sStart="null" offset="82" sid="r9.normal.j.0081" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="Elucidating the mechanisms at play during readthrough may help understand normal translation termination." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="2797" end="2803" sStart="null" offset="82" sid="r9.normal.j.0081" wn="1" wnkey="normal%3:00:01::" annotator="anfahmy" text="Elucidating the mechanisms at play during readthrough may help understand normal translation termination." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="10379" end="10385" sStart="null" offset="139" sid="r8.live.v.0240" wn="5" wnkey="live%2:42:00::" annotator="cgozo" text="Since in vitro translation may not always accurately reflect the in vivo conditions, we chosed to perform such analyses in living mouse cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="15575" end="15579" sStart="null" offset="67" sid="r10.high.j.0879" wn="1" wnkey="high%3:00:02::" annotator="cgozo" text="It is striking that the CAA UAG CAA UUA sequence directs a high readthrough in several very different eukaryotes." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="17160" end="17164" sStart="null" offset="49" sid="r10.help.v.0950" wn="3" wnkey="help%2:42:00::" annotator="anfahmy" text="Analyzing DNA sequence data bases should help in identifying such putative physiological recoding events." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="9392" end="9396" sStart="null" offset="56" sid="r9.fold.v.0987" wn="2147483645" wnkey="null" annotator="cgozo" text="The results are shown in Table 3. A 50 to 100 fold increase in readthrough activities was observed, demonstrating that very high levels of suppression were reached." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="14536" end="14540" sStart="null" offset="51" sid="r9.fold.v.0115" wn="2147483645" wnkey="null" annotator="cgozo" text="A drastic effect on readthrough, up to 100 fold, was observed." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="11009" end="11013" sStart="null" offset="114" sid="r9.fold.v.0988" wn="2147483645" wnkey="null" annotator="brubin" text="We found that single changes in this sequence were sufficient to decrease readthrough by up to 30 fold in vivo." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-3.anc" start="12215" end="12219" sStart="null" offset="103" sid="r9.fold.v.0872" wn="2147483645" wnkey="null" annotator="brubin" text="We found that the same amino acid can drive very different readthrough efficiencies (5 fold differences between GGA and GGU), suggesting that the amino acid itself does not play a major role in readthrough efficiency." />
  </sentences>
</list>